Research map: Sarcopenia in postmenopausal patients with type 1 diabetes mellitus: characteristics of functional, laboratory, and instrumental indicators

Back to the article

Papers in this map

  1. Sarcopenia: revised European consensus on definition and diagnosis · Alfonso José Cruz-Jentoft · 2018 · 14145 citations · Cited by this paper
  2. Prolactin, Estrogen, HbA1c and Interleukin-12 in Iraqi Smokers Single Females · 2025 · Related
  3. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment · Liang‐Kung Chen · 2020 · 7169 citations · Cited by this paper
  4. Changes in bone tissue energy metabolism in diabetes mellitus and aging as a cause of increased skeletal fragility · 2026 · Related
  5. Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium · Shalender Bhasin · 2020 · 719 citations · Cited by this paper
  6. The role of trace elements in the pathogenesis of ocular surface diseases in type 2 diabetes mellitus: current concepts and clinical perspectives · 2026 · Related
  7. Diabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells · Donna M. D’Souza · 2013 · 226 citations · Cited by this paper
  8. Immunogenetic–metabolic profiles in clinically healthy siblings of patients with type 1 diabetes · 2026 · Related
  9. Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults · Laura Bee Gek Tay · 2015 · 177 citations · Cited by this paper
  10. Different weight loss strategies and their impact on fat and muscle tissue · 2026 · Related
  11. Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay · H. Robert Bergen · 2015 · 137 citations · Cited by this paper
  12. Prevalence of insulin resistance based on the estimated rate of glucose utilization among adult patients with type 1 diabetes and its role in predicting diabetic complications · 2025 · Related
  13. Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men · Elizaveta Fife · 2018 · 77 citations · Cited by this paper
  14. Finerenone: features of action, current evidence base and examples of clinical application · 2026 · Related
  15. Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women · Marlene Hofmann · 2015 · 76 citations · Cited by this paper
  16. Clinical and epidemiological characteristics of diabetes mellitus in children of the Republic of Sakha (Yakutia) · 2026 · Related
  17. Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging · Aurélie Ladang · 2023 · 76 citations · Cited by this paper
  18. Characteristics of type 1 diabetic patients with psychoorganic syndrome · 2026 · Related
  19. Loss of the adipokine lipocalin-2 impairs satellite cell activation and skeletal muscle regeneration · Irena A. Rebalka · 2018 · 50 citations · Cited by this paper
  20. Impact of weight loss on GLP-1, glucagon and oxyntomodulin secretion in patients with obesity and type 2 diabetes · 2025 · Related
  21. Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study · Kenta Moriwaki · 2019 · 48 citations · Cited by this paper
  22. Muscle and serum myostatin expression in type 1 diabetes · Athan G. Dial · 2020 · 24 citations · Cited by this paper
  23. Lipocalin 2 increases after high‐intensity exercise in humans and influences muscle gene expression and differentiation in mice · Marco Ponzetti · 2021 · 23 citations · Cited by this paper
  24. Mitochondrial Dysfunction: Linking Type 1 Diabetes and Sarcopenia · Stephen E. Alway · 2019 · 13 citations · Cited by this paper
  25. Muscle quality, physical performance, and comorbidity are predicted by circulating procollagen type III N-terminal peptide (P3NP): the InCHIANTI follow-up study · Raffaello Pellegrino · 2023 · 9 citations · Cited by this paper
  26. Changes in skeletal muscle in diabetes mellitus · Olga Alexandrovna Shatskaya · 2024 · 2 citations · Cited by this paper
  27. Serum cystatin C levels are decreased in type 1 diabetes mellitus patients with diabetic ketoacidosis · Yiping Cheng · 2020 · 1 citation · Cited by this paper
  28. Sarcopenia: features of manifestation in patients with diabetes mellitus · Ya. L. Naumenava · 2024 · 1 citation · Cited by this paper
  29. O papel da cistatina C na injúria renal em crianças e adolescentes com diabetes mellitus tipo 1: uma revisão sistemática · Νikolaos Gkiourtzis · 2025 · 1 citation · Cited by this paper
  30. Clinical, laboratory and instrumental aspects of sarcopenia diagnostics · A. S. Zhdanova · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)